303 related articles for article (PubMed ID: 2543276)
1. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.
Gladue RP; Bright GM; Isaacson RE; Newborg MF
Antimicrob Agents Chemother; 1989 Mar; 33(3):277-82. PubMed ID: 2543276
[TBL] [Abstract][Full Text] [Related]
2. Phagocyte uptake and transport of azithromycin.
McDonald PJ; Pruul H
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):828-33. PubMed ID: 1662626
[TBL] [Abstract][Full Text] [Related]
3. Uptake and subcellular distribution of azithromycin in human phagocytic cells. Demonstration of the antibiotic in neutrophil polymorphonuclear leucocytes and monocytes by autoradiography and electron microscopy.
Wildfeuer A; Reisert I; Laufen H
Arzneimittelforschung; 1993 Apr; 43(4):484-6. PubMed ID: 8388213
[TBL] [Abstract][Full Text] [Related]
4. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes.
Fietta A; Merlini C; Gialdroni Grassi G
J Chemother; 1997 Feb; 9(1):23-31. PubMed ID: 9106014
[TBL] [Abstract][Full Text] [Related]
5. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.
Hand WL; King-Thompson NL
Antimicrob Agents Chemother; 1986 Jan; 29(1):135-40. PubMed ID: 3790206
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes.
Silvestri M; Oddera S; Eftimiadi C; Rossi GA
J Antimicrob Chemother; 1995 Dec; 36(6):941-50. PubMed ID: 8821593
[TBL] [Abstract][Full Text] [Related]
7. Intracellular accumulation of azithromycin by cultured human fibroblasts.
Gladue RP; Snider ME
Antimicrob Agents Chemother; 1990 Jun; 34(6):1056-60. PubMed ID: 2168141
[TBL] [Abstract][Full Text] [Related]
8. Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes.
Wildfeuer A; Laufen H; Müller-Wening D; Haferkamp O
Arzneimittelforschung; 1989 Jul; 39(7):755-8. PubMed ID: 2551303
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of azithromycin uptake in human polymorphonuclear leucocytes.
Laufen H; Wildfeuer A; Lach P
Arzneimittelforschung; 1990 Jun; 40(6):686-9. PubMed ID: 2168704
[TBL] [Abstract][Full Text] [Related]
10. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.
Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
Antimicrob Agents Chemother; 1992 Jul; 36(7):1412-7. PubMed ID: 1324644
[TBL] [Abstract][Full Text] [Related]
11. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.
Frank MO; Sullivan GW; Carper HT; Mandell GL
Antimicrob Agents Chemother; 1992 Dec; 36(12):2584-8. PubMed ID: 1336337
[TBL] [Abstract][Full Text] [Related]
12. The activity of azithromycin in animal models of infection.
Pechère JC
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):821-7. PubMed ID: 1662625
[TBL] [Abstract][Full Text] [Related]
13. Preferential concentration of azithromycin in an infected mouse thigh model.
Retsema JA; Bergeron JM; Girard D; Milisen WB; Girard AE
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():5-16. PubMed ID: 8396096
[TBL] [Abstract][Full Text] [Related]
14. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Pascual A; López-López G; Aragón J; Perea EJ
Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro.
Labro MT; Abdelghaffar H; Babin-Chevaye C
Antimicrob Agents Chemother; 2004 Apr; 48(4):1096-104. PubMed ID: 15047507
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
Girard AE; Girard D; English AR; Gootz TD; Cimochowski CR; Faiella JA; Haskell SL; Retsema JA
Antimicrob Agents Chemother; 1987 Dec; 31(12):1948-54. PubMed ID: 2830841
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence.
Bonnet M; Van der Auwera P
Antimicrob Agents Chemother; 1992 Jun; 36(6):1302-9. PubMed ID: 1329619
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes.
Hand WL; Hand DL
Int J Antimicrob Agents; 2001 Nov; 18(5):419-25. PubMed ID: 11711255
[TBL] [Abstract][Full Text] [Related]
19. [Transport to an infected site of azithromycin by phagocyte cells].
Enogaki K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():60-71. PubMed ID: 12572089
[TBL] [Abstract][Full Text] [Related]
20. In-vitro concentration of azithromycin in human phagocytic cells.
Panteix G; Guillaumond B; Harf R; Desbos A; Sapin V; Leclercq M; Perrin-Fayolle M
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():1-4. PubMed ID: 8396080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
